AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter explores Eli Lilly's novel approach to distributing its weight loss drug ZEPBOWN, allowing patients to self-fill vials at a monthly cost of $399. It discusses the potential benefits and challenges of this self-administration method in response to supply shortages and patient preferences.